Literature DB >> 24633307

Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes.

Daniel Weiss1, Mario Koopmann, Markus Stenner, Eleftherios Savvas, Claudia Rudack.   

Abstract

Carcinoma in cervical lymph nodes of unknown origin represents a rare clinical entity where optimal diagnostic and therapeutic management is still a widely debated issue. Molecular classification of these metastases is thus of utmost importance. We analyzed the expression of eight basic molecular markers in 26 metastases from unknown primaries, 31 metastases from overt primaries and their associated primaries. Medical records of the respective patients were reviewed for main clinicopathological parameters. The expression rates showed no significant differences between the two tumor entities, neither in absolute terms nor in comparison among the parameters. Surprisingly, patients with metastases from unknown primary demonstrated improved progression-free survival (p = 0.046) despite advanced age (p = 0.029), advanced nodal stage (p = 0.006) and higher incidence of extracapsular spread (p = 0.045) compared to patients with metastases from overt primaries. Presence of extracapsular spread was associated with increased expression of epidermal growth factor receptor in metastases from overt primaries (p = 0.035) and reduced expression of matrix metalloproteinase-2 in metastases from unknown primary (p = 0.031). We thus conclude that cervical metastases from unknown and overt primaries show similarities in their molecular profile, but fundamental differences in clinical parameter.

Entities:  

Mesh:

Year:  2014        PMID: 24633307     DOI: 10.1007/s00405-014-2980-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

Review 1.  Cancer of unknown primary: does treatment modality make a difference?

Authors:  Ashley E Balaker; Elliot Abemayor; David Elashoff; Maie A St John
Journal:  Laryngoscope       Date:  2012-04-26       Impact factor: 3.325

2.  Radiotherapeutic management of cervical lymph node metastases from an unknown primary site.

Authors:  Stephanie M Perkins; Christopher R Spencer; Rebecca D Chernock; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; David I Kuperman; Wade L Thorstad
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-07

3.  Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.

Authors:  J Califano; W H Westra; W Koch; G Meininger; A Reed; L Yip; J O Boyle; F Lonardo; D Sidransky
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

Review 4.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

Review 5.  Cancer of unknown primary site.

Authors:  Nicholas Pavlidis; George Pentheroudakis
Journal:  Lancet       Date:  2012-03-12       Impact factor: 79.321

6.  Detection of the primary lesion in patients with cervical metastases from unknown primary tumors with narrow band imaging endoscopy: preliminary report.

Authors:  In Sun Ryu; Seung-Ho Choi; Do Hun Kim; Myung Woul Han; Jong-Lyel Roh; Sang Yoon Kim; Soon Yuhl Nam
Journal:  Head Neck       Date:  2012-04-08       Impact factor: 3.147

7.  Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients.

Authors:  Debora Beldì; Barbara A Jereczek-Fossa; Alberto D'Onofrio; Giuseppina Gambaro; Maria Rosaria Fiore; Francesco Pia; Fausto Chiesa; Roberto Orecchia; Marco Krengli
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-22       Impact factor: 7.038

Review 8.  Cancer of unknown primary site: missing primary or missing biology?

Authors:  George Pentheroudakis; Evangelos Briasoulis; Nicholas Pavlidis
Journal:  Oncologist       Date:  2007-04

9.  microRNA evaluation of unknown primary lesions in the head and neck.

Authors:  Emma V Barker; Nilva K Cervigne; Patricia P Reis; Rashmi S Goswami; Wei Xu; Ilan Weinreb; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

10.  Diagnostic strategies in cervical carcinoma of an unknown primary (CUP).

Authors:  Inge Haas; Thomas K Hoffmann; Rainer Engers; Uwe Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-05-01       Impact factor: 2.503

View more
  1 in total

1.  Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck.

Authors:  Chunmiao Xu; Junhui Yuan; Wei Du; Junfu Wu; Qigen Fang; Xu Zhang; Hailiang Li
Journal:  Front Oncol       Date:  2020-01-29       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.